tlooto
Sign up
Medicine

Comments on “Safety and pharmacology of AMY109, a long-acting anti–interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial”

S. Dokania, P. Aphale, H. Shekhar

2026.2.1F&S Reports

DOI: 10.1016/j.xfre.2025.09.007

Abstract

first-in-human

Citation format

DOKANIA, S.; APHALE, P.; SHEKHAR, H. Comments on “safety and pharmacology of AMY109, a long-acting anti–interleukin-8 antibody, for endometriosis: A double-blind, randomized phase 1 trial”. F&S Reports, 2026, 7(1): 94–94.